Global Vaccines Market to Experience Exponential Growth by 2023

1
Opportunity Analysis and Industry Forecast,
2016-2023
Vaccines Market
Global Opportunity Analysis and Industry
Forecast, 2017-2023
No. of Pages 240 Publish May 2017
2
 
Vaccines Market
The emerging vaccines for malaria, dengue, Zika,
HIV, Ebola, and other serotypes are expected to
propel the market growth in the forthcoming
years. In addition, the ongoing vaccination
programs and the recommendation doses for
respective vaccine in the developing and the
under-developed countries have supplemented the
market growth. - Sriram Radhakrishnan
3
 
Vaccines Market Overview

• Global Vaccines Market was valued at 31,216
  million in 2016, and is expected to reach 65,148
  million in 2023, and register a CAGR of 10.9,
  during the forecast period, 2017- 2023.
• Vaccine is a biological preparation that is
  administered to produce acquired immunity in
  patients. Administration of vaccines aids to
  enhance the immune response against a specific
  pathogen.
• Vaccinations play a crucial role to maintain
  sustainable health of people across different
  countries hence, they are employed in various
  regional disease-prevention strategies.
• The demand for vaccinations has increased over
  the last few years, owing to the increase in
  incidence of both viral and bacterial infectious
  diseases.

4
A
 
Vaccines Market Key Benefits

• It provides an in-depth analysis of current
  trends and future estimations to elucidate the
  imminent investment pockets
• It offers a comprehensive analysis of factors
  that drive and restrict the market growth
• It presents a quantitative analysis of the
  industry to enable the stakeholders to capitalize
  on the prevailing market opportunities
• It provides an extensive analysis of key segments
  to understand the type of products and
  indications used globally
• It includes profiles of key market players and
  their strategies to comprehend the competitive
  outlook of the market.

5
 
Vaccines Market Key Findings

• The recombinant vaccines segment is anticipated
  to grow at the highest growth rate during the
  forecast period.
• The human papilloma virus (HPV) vaccines segment
  is expected to grow at a rapid rate, registering
  a CAGR of 12.4 from 2017 to 2023.
• North America dominated the global vaccines
  market, accounting for maximum share of overall
  market in 2016.
• Asia-Pacific is exhibited to grow at a high
  growth rate of 12.0, owing to the high demand
  for vaccination in densely populated area, such
  as India and China.
• The pediatric vaccines segment generated highest
  revenue in 2016, and is expected to continue its
  dominance in the future as well.

6
 
Vaccines Market Top Winning Segmentation
7
 
Vaccines Market By End Use
8
 
Vaccines Market Drivers, Restraints, and
Opportunities
9
 
Vaccines Market By Geography

• North America, Europe, Asia-Pacific, LAMEA

10
 
Key Players in Industry

• Astellas Pharma Inc.
• Astrazeneca Plc. (Medimmune, LLC.)
• CSL Limited
• Emergent Biosolutions, Inc.
• Glaxosmithkline Plc.
• Johnson Johnson
• Merck Co., Inc.
• Pfizer Inc.
• Sanofi Pasteur
• Serum Institute of India Pvt. Ltd.
• Download Sample Copy of this Report Click Here

11
 
 
Thank You! For More Details
Visit us at
https//www.alliedmarketresearch.com/vaccines-mark
et
Follow Us On